Expert Emphasizes Importance of Cancer Prevention and Screenings on World Cancer Day

Article

An expert from Ochsner Health discusses the essential role positive lifestyle habits and regular screenings play in preventing cancer diagnoses.

Regular screenings and follow-ups along with reducing risk factors is imperative to preventing the development and spread of cancer; the consequences of avoiding such care may be evident in the number of cancer diagnoses following the COVID-19 pandemic, according to Jonathan Mizrahi, MD.

In recognition of World Cancer Day, CancerNetwork® spoke with Mizrahi, a board-certified gastrointestinal medical oncologist at Ochsner Health in New Orleans, Louisiana, regarding where he feels the oncology field should be focused such as screenings and prevention, as well as other barriers to care that some populations may face.

Mizrahi suggested that there is still work to be done in addressing inequities in the United States related to access to healthcare and cancer screenings.

Transcript:

World Cancer Day is very important. It gives us a reminder of all the work we still need to do both here in the United States [and] globally. There are gaps and inequalities that exist internally. Here, there are disparities within our country of patients who have access to care and screening, and there are disparities that obviously exist between more developed countries and developing countries. We need to remember the effects of COVID-19, what they had on patients who were getting screened, and how that's going to affect the status of patients we're going to see down the line.

The best thing we can do for our patients is making sure they're getting screened and getting seen by their primary care doctors and being followed up regularly, as well as reducing their risk factors for developing cancers. By the time they're seeing me and my medical oncology colleagues, it's often too late. I'd rather have to see fewer patients because we're catching them early.

On World Cancer Day, [we must] re-energize our focus on prevention, screening, good lifestyle habits, and then moving the needle forward in terms of what therapies we can offer our patients who do get diagnosed with cancer.

Recent Videos
According to John Henson, MD, “What we need are better treatments to control the [brain] tumor once it’s detected.”
First-degree relatives of patients who passed away from pancreatic cancer should be genetically tested to identify their risk for the disease.
Destigmatizing cancer care for incarcerated patients may help ensure that they feel supported both in their treatment and their humanity.
A lower percentage of patients who were released within 1 year of incarceration received guideline-concurrent care vs incarcerated patients.
A collaboration between the Connecticut Departments of Health and Corrections and the COPPER Center aimed to improve outcomes among incarcerated patients.
Computational models help researchers anticipate how ADCs may behave in later lines of development, while they are still in the early stages.
ADC payloads with high levels of potency can sometimes lead to higher levels of toxicity, which can eliminate the therapeutic window for patients with cancer.
According to Greg Thurber, PhD, target-mediated uptake is the biggest driver of efficacy for antibody-drug conjugates as a cancer treatment.
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight what to expect at the 43rd Annual Chemotherapy Foundation Symposium, such as new chemotherapeutics and targeted therapies.
In neuroendocrine tumor management, patients with insulinoma may be at risk of severe hypoglycemia following receipt of GLP-1 receptor agonists.
Related Content